Mesalamine Delayed Release Tablets and Siltuximab Intravenous
Determining the interaction of Mesalamine Delayed Release Tablets and Siltuximab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: mesalamine
Brand name: Apriso, Asacol HD, Delzicol, Lialda, Pentasa, Canasa, Canasa Pac, Rowasa, SfRowasa
Synonyms: Mesalamine
Generic Name: siltuximab
Brand name: Sylvant
Synonyms: Siltuximab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Mesalamine Delayed Release Tablets-Silvadene
- Mesalamine Delayed Release Tablets-Silvadene Topical
- Mesalamine Delayed Release Tablets-SilvaSorb
- Mesalamine Delayed Release Tablets-Silver
- Mesalamine Delayed Release Tablets-Silver Nitrate
- Mesalamine Delayed Release Tablets-Silver Nitrate Applicators
- Siltuximab Intravenous-Mesalamine Long-Acting Capsules (Apriso)
- Siltuximab Intravenous-Mesalamine Long-Acting Capsules (Delzicol)
- Siltuximab Intravenous-Mesalamine Long-Acting Capsules (Pentasa)
- Siltuximab Intravenous-Mesalamine rectal
- Siltuximab Intravenous-Mesalamine Rectal Enema
- Siltuximab Intravenous-Mesalamine Rectal Suspension